Cellavision Q4: Small Adjustments
Redeyes view on the Q4 report. We make minor adjustments to our estimates for 2022, with a slightly lower growth assumption. We adjust our Base case to SEK 340 (330) per share with an unchanged fair value range.
MH
Mats Hyttinge
Disclosures and disclaimers